Royalty Pharma's market cap is currently ―. The company's EPS TTM is $2.535; its P/E ratio is 11.93; and it has a dividend yield of 2.68%. Royalty Pharma is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $0.95. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 596.07M	$ 536.31M	$ 501.35M	$ 664.69M	$ 565.75M
Gross Profit	$ 596.07M	$ 536.31M	$ 538.20M	$ 683.97M	$ 565.75M
EBIT	$ 764.84M	$ 168.11M	$ 398.29M	$ 539.34M	$ -606.93M
EBITDA	$ 764.84M	-	$ 398.29M	$ 539.34M	$ -606.93M
Net Income Common Stockholders	$ 494.34M	$ 72.11M	$ 227.63M	$ 340.75M	$ -456.08M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 495.31M	$ 941.75M	$ 2.18B	$ 1.98B	$ 1.74B
Total Assets	$ 16.38B	$ 15.86B	$ 17.12B	$ 17.07B	$ 16.81B
Total Debt	$ 6.14B	$ 6.13B	$ 7.13B	$ 7.12B	$ 7.12B
Net Debt	$ 5.64B	$ 5.19B	$ 4.95B	$ 5.14B	$ 5.38B
Total Liabilities	$ 6.30B	$ 6.27B	$ 7.31B	$ 7.25B	$ 7.29B
Stockholders Equity	$ 6.53B	$ 6.14B	$ 6.28B	$ 5.95B	$ 5.63B
Cash Flow	-
Free Cash Flow	$ 772.63M	-	$ 607.82M	$ 1.03B	$ 569.93M
Operating Cash Flow	$ 772.63M	$ 490.27M	$ 607.82M	$ 1.03B	$ 569.93M
Investing Cash Flow	$ -1.00B	$ -450.66M	$ -63.43M	$ -558.53M	$ 414.74M
Financing Cash Flow	$ -231.89M	$ -1.36B	$ -347.00M	$ -210.37M	$ -265.55M

Currency in USD

Royalty Pharma Earnings and Revenue History

Income Statement >

Royalty Pharma Debt to Assets

Balance Sheet >

Royalty Pharma Cash Flow

Cash Flow >

Royalty Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing